Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bonnie L Hall

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Opinion in Structural Biology|August 30, 2021
Undergraduate structural biology education: A shift from users to developers of computation and simulation toolsAshley Ringer McDonald, Rebecca Roberts, Julia R Koeppe, et al.
Molecular Therapy. Oncology|April 10, 2024
Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumorsSelene Ingusci, Bonnie L Hall, Justus B Cohen, et al.
Handbook of Clinical Neurology|September 28, 2024
Viral vectors for gene delivery to the central nervous systemSelene Ingusci, Bonnie L Hall, William F Goins, et al.
Molecular Therapy. Methods & Clinical Development|July 31, 2023
Novel mutations in U<sub>L</sub>24 and gH rescue efficient infection of an HSV vector retargeted to TrkAMarco Marzulli, Bonnie L Hall, Mingdi Zhang, et al.
International Journal of Molecular Sciences|November 25, 2020
Generation of an Oncolytic Herpes Simplex Viral Vector Completely Retargeted to the GDNF Receptor GFRα1 for Specific Infection of Breast Cancer CellsBonnie L Hall, Daniela Leronni, Yoshitaka Miyagawa, et al.
Molecular Therapy. Methods & Clinical Development|February 12, 2020
Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing AntibodiesCeren Tuzmen, Tina M Cairns, Doina Atanasiu, et al.
Molecular Therapy Oncolytics|September 23, 2021
Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitmentJoseph W Jackson, Bonnie L Hall, Marco Marzulli, et al.
Molecular Therapy. Oncology|December 15, 2025
An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastomaJoseph W Jackson, Bonnie L Hall, Chaim Sneiderman, et al.
Proteins|September 28, 2021
Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first 6 months of the COVID-19 pandemicJoseph H Lubin, Christine Zardecki, Elliott M Dolan, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemicJoseph H Lubin, Christine Zardecki, Elliott M Dolan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Structural Biology|August 30, 2021
Undergraduate structural biology education: A shift from users to developers of computation and simulation toolsAshley Ringer McDonald, Rebecca Roberts, Julia R Koeppe, et al.
Molecular Therapy. Oncology|April 10, 2024
Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumorsSelene Ingusci, Bonnie L Hall, Justus B Cohen, et al.
Handbook of Clinical Neurology|September 28, 2024
Viral vectors for gene delivery to the central nervous systemSelene Ingusci, Bonnie L Hall, William F Goins, et al.
Molecular Therapy. Methods & Clinical Development|July 31, 2023
Novel mutations in U<sub>L</sub>24 and gH rescue efficient infection of an HSV vector retargeted to TrkAMarco Marzulli, Bonnie L Hall, Mingdi Zhang, et al.
International Journal of Molecular Sciences|November 25, 2020
Generation of an Oncolytic Herpes Simplex Viral Vector Completely Retargeted to the GDNF Receptor GFRα1 for Specific Infection of Breast Cancer CellsBonnie L Hall, Daniela Leronni, Yoshitaka Miyagawa, et al.
Molecular Therapy. Methods & Clinical Development|February 12, 2020
Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing AntibodiesCeren Tuzmen, Tina M Cairns, Doina Atanasiu, et al.
Molecular Therapy Oncolytics|September 23, 2021
Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitmentJoseph W Jackson, Bonnie L Hall, Marco Marzulli, et al.
Molecular Therapy. Oncology|December 15, 2025
An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastomaJoseph W Jackson, Bonnie L Hall, Chaim Sneiderman, et al.
Proteins|September 28, 2021
Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first 6 months of the COVID-19 pandemicJoseph H Lubin, Christine Zardecki, Elliott M Dolan, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemicJoseph H Lubin, Christine Zardecki, Elliott M Dolan, et al.
Pageof 1